US Stock MarketDetailed Quotes

MEIP MEI Pharma

Watchlist

2.8100
+0.0100+0.36%

Close Nov 21 16:00 ET

2.8100
0.00000.00%

Post 16:07 ET

18.72MMarket Cap-402P/E (TTM)

MEI Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Sep 30, 2024

(FY)Jun 30, 2024

(Q4)Jun 30, 2024

(Q3)Mar 31, 2024

(Q2)Dec 31, 2023

(Q1)Sep 30, 2023

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

Total revenue

33.76%65.3M

647.96%65.3M

19.95%48.82M

-87.23%1.46M

-39.20%5.89M

176.66%32.74M

Operating revenue

--0

33.76%65.3M

--0

647.96%65.3M

19.95%48.82M

-87.23%1.46M

-39.20%5.89M

176.66%32.74M

Cost of revenue

Gross profit

Operating expense

-16.61%8.35M

-53.43%39.86M

-35.54%8.08M

-55.89%9.83M

-49.89%11.93M

-62.83%10.02M

-26.34%85.58M

-54.59%12.54M

-28.69%22.29M

-19.17%23.81M

Selling and administrative expenses

-20.55%5.19M

-29.69%23.3M

-58.49%4.14M

-35.82%4.61M

-5.63%8.02M

-12.76%6.53M

8.48%33.13M

72.71%9.97M

-19.62%7.18M

7.19%8.5M

-General and administrative expense

-20.55%5.19M

-29.69%23.3M

-58.49%4.14M

-35.82%4.61M

-5.63%8.02M

-12.76%6.53M

8.48%33.13M

72.71%9.97M

-19.62%7.18M

7.19%8.5M

Research and development costs

-9.24%3.16M

-68.43%16.56M

53.46%3.94M

-65.44%5.22M

-74.45%3.91M

-82.09%3.49M

-38.76%52.45M

-88.23%2.57M

-32.32%15.1M

-28.88%15.31M

Operating profit

-115.11%-8.35M

169.20%25.44M

27.07%-8.08M

40.03%-9.83M

-233.65%-11.93M

403.42%55.28M

51.30%-36.76M

31.59%-11.08M

23.97%-16.39M

150.64%8.93M

Net non-operating interest income expense

-67.55%355K

-2.03%3.28M

-42.80%608K

-26.23%706K

2.84%869K

127.92%1.09M

1,077.82%3.35M

416.02%1.06M

1,495.00%957K

7,581.82%845K

Non-operating interest income

-67.55%355K

-2.03%3.28M

-42.80%608K

-26.23%706K

2.84%869K

127.92%1.09M

1,077.82%3.35M

416.02%1.06M

1,495.00%957K

7,581.82%845K

Other net income (expense)

-900.00%-10K

-791.97%-10.94M

-91,008.33%-10.93M

0.00%-4K

-100.41%-2K

-100.09%-1K

-92.38%1.58M

83.56%-12K

-100.03%-4K

-91.17%482K

Gain on sale of security

----

-92.28%1.6M

--0

----

-91.10%486K

Special income (charges)

----

---10.9M

----

--0

----

-Less:Impairment of capital assets

----

--10.9M

----

--0

----

Other non- operating income (expenses)

-900.00%-10K

-86.36%-41K

-183.33%-34K

0.00%-4K

50.00%-2K

50.00%-1K

-266.67%-22K

---12K

---4K

Income before tax

-114.20%-8.01M

155.84%17.78M

-83.53%-18.41M

40.88%-9.13M

-207.90%-11.06M

439.11%56.37M

41.53%-31.84M

37.56%-10.03M

-76.94%-15.44M

184.35%10.25M

Income tax

Net income

-114.20%-8.01M

155.84%17.78M

-83.53%-18.41M

40.88%-9.13M

-207.90%-11.06M

439.11%56.37M

41.53%-31.84M

37.56%-10.03M

-76.94%-15.44M

184.35%10.25M

Net income continuous Operations

-114.20%-8.01M

155.84%17.78M

-83.53%-18.41M

40.88%-9.13M

-207.90%-11.06M

439.11%56.37M

41.53%-31.84M

37.56%-10.03M

-76.94%-15.44M

184.35%10.25M

Minority interest income

Net income attributable to the parent company

-114.20%-8.01M

155.84%17.78M

-83.53%-18.41M

40.88%-9.13M

-207.90%-11.06M

439.11%56.37M

41.53%-31.84M

37.56%-10.03M

-76.94%-15.44M

184.35%10.25M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-114.20%-8.01M

155.84%17.78M

-83.53%-18.41M

40.88%-9.13M

-207.90%-11.06M

439.11%56.37M

41.53%-31.84M

37.56%-10.03M

-76.94%-15.44M

184.35%10.25M

Basic earnings per share

-114.18%-1.2

155.86%2.67

-82.78%-2.76

40.95%-1.37

-207.79%-1.66

439.76%8.46

45.37%-4.78

38.11%-1.51

-77.10%-2.32

177.00%1.54

Diluted earnings per share

-114.18%-1.2

155.86%2.67

-82.78%-2.76

40.95%-1.37

-207.79%-1.66

439.76%8.46

52.15%-4.78

38.11%-1.51

-77.10%-2.32

155.00%1.54

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Sep 30, 2024	(FY)Jun 30, 2024	(Q4)Jun 30, 2024	(Q3)Mar 31, 2024	(Q2)Dec 31, 2023	(Q1)Sep 30, 2023	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022
Total revenue	0	33.76%65.3M	0	0	0	647.96%65.3M	19.95%48.82M	-87.23%1.46M	-39.20%5.89M	176.66%32.74M
Operating revenue	--0	33.76%65.3M	--0	--0	--0	647.96%65.3M	19.95%48.82M	-87.23%1.46M	-39.20%5.89M	176.66%32.74M
Cost of revenue
Gross profit
Operating expense	-16.61%8.35M	-53.43%39.86M	-35.54%8.08M	-55.89%9.83M	-49.89%11.93M	-62.83%10.02M	-26.34%85.58M	-54.59%12.54M	-28.69%22.29M	-19.17%23.81M
Selling and administrative expenses	-20.55%5.19M	-29.69%23.3M	-58.49%4.14M	-35.82%4.61M	-5.63%8.02M	-12.76%6.53M	8.48%33.13M	72.71%9.97M	-19.62%7.18M	7.19%8.5M
-General and administrative expense	-20.55%5.19M	-29.69%23.3M	-58.49%4.14M	-35.82%4.61M	-5.63%8.02M	-12.76%6.53M	8.48%33.13M	72.71%9.97M	-19.62%7.18M	7.19%8.5M
Research and development costs	-9.24%3.16M	-68.43%16.56M	53.46%3.94M	-65.44%5.22M	-74.45%3.91M	-82.09%3.49M	-38.76%52.45M	-88.23%2.57M	-32.32%15.1M	-28.88%15.31M
Operating profit	-115.11%-8.35M	169.20%25.44M	27.07%-8.08M	40.03%-9.83M	-233.65%-11.93M	403.42%55.28M	51.30%-36.76M	31.59%-11.08M	23.97%-16.39M	150.64%8.93M
Net non-operating interest income expense	-67.55%355K	-2.03%3.28M	-42.80%608K	-26.23%706K	2.84%869K	127.92%1.09M	1,077.82%3.35M	416.02%1.06M	1,495.00%957K	7,581.82%845K
Non-operating interest income	-67.55%355K	-2.03%3.28M	-42.80%608K	-26.23%706K	2.84%869K	127.92%1.09M	1,077.82%3.35M	416.02%1.06M	1,495.00%957K	7,581.82%845K
Other net income (expense)	-900.00%-10K	-791.97%-10.94M	-91,008.33%-10.93M	0.00%-4K	-100.41%-2K	-100.09%-1K	-92.38%1.58M	83.56%-12K	-100.03%-4K	-91.17%482K
Gain on sale of security	----	----	----	----	----	----	-92.28%1.6M	--0	----	-91.10%486K
Special income (charges)	----	---10.9M	----	----	----	----	--0	----	----	----
-Less:Impairment of capital assets	----	--10.9M	----	----	----	----	--0	----	----	----
Other non- operating income (expenses)	-900.00%-10K	-86.36%-41K	-183.33%-34K	0.00%-4K	50.00%-2K	50.00%-1K	-266.67%-22K	---12K	---4K	---4K
Income before tax	-114.20%-8.01M	155.84%17.78M	-83.53%-18.41M	40.88%-9.13M	-207.90%-11.06M	439.11%56.37M	41.53%-31.84M	37.56%-10.03M	-76.94%-15.44M	184.35%10.25M
Income tax
Net income	-114.20%-8.01M	155.84%17.78M	-83.53%-18.41M	40.88%-9.13M	-207.90%-11.06M	439.11%56.37M	41.53%-31.84M	37.56%-10.03M	-76.94%-15.44M	184.35%10.25M
Net income continuous Operations	-114.20%-8.01M	155.84%17.78M	-83.53%-18.41M	40.88%-9.13M	-207.90%-11.06M	439.11%56.37M	41.53%-31.84M	37.56%-10.03M	-76.94%-15.44M	184.35%10.25M
Minority interest income
Net income attributable to the parent company	-114.20%-8.01M	155.84%17.78M	-83.53%-18.41M	40.88%-9.13M	-207.90%-11.06M	439.11%56.37M	41.53%-31.84M	37.56%-10.03M	-76.94%-15.44M	184.35%10.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-114.20%-8.01M	155.84%17.78M	-83.53%-18.41M	40.88%-9.13M	-207.90%-11.06M	439.11%56.37M	41.53%-31.84M	37.56%-10.03M	-76.94%-15.44M	184.35%10.25M
Basic earnings per share	-114.18%-1.2	155.86%2.67	-82.78%-2.76	40.95%-1.37	-207.79%-1.66	439.76%8.46	45.37%-4.78	38.11%-1.51	-77.10%-2.32	177.00%1.54
Diluted earnings per share	-114.18%-1.2	155.86%2.67	-82.78%-2.76	40.95%-1.37	-207.79%-1.66	439.76%8.46	52.15%-4.78	38.11%-1.51	-77.10%-2.32	155.00%1.54
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data